Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Poodles of the World

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Faculty

Events

Resource Hubs

DOACs: 60 Second Insights

Published: 18 June 2018

Views:
9
Likes:
7

Views:
9
Likes:
7
Share:

Now Playing
Part 1 | Session 5 of 11
Do you have a DOAC of choice?
Moussa Mansour

Up Next
Part 1 | Session 6 How important are reversal agents? - Christoper Cannon
Christopher P Cannon
Part 1 | Session 7 How important are reversal agents? - Moussa Mansour
Moussa Mansour
Part 1 | Session 8 Are you once-daily or twice-daily? - Christopher Cannon
Christopher P Cannon
Part 1 | Session 9 Are you once-daily or twice-daily? - Moussa Mansour
Moussa Mansour
Part 1 | Session 10 Is RCT or real-world data more important to you? - Christopher Cannon
Christopher P Cannon
Part 1 | Session 11 Is RCT or real-world data more important to you? - Moussa Mansour
Moussa Mansour

Part 1 | Session 1 What are the challeges of DOACs and are alternatives needed? Christopher P Cannon

Part 1 | Session 2 What factors influence your choice of DOAC? Christopher P Cannon

Part 1 | Session 3 Do you have a DOAC you prescribe more frequently? Christopher P Cannon

Part 1 | Session 4 What are the most important anticoagulation clinical trials? Christopher P Cannon

Average (ratings)

No ratings

Your rating

Overview

Christopher Cannon and Moussa Mansour share their thoughts on DOACs in a series of 60-second interviews

More from this programme

Part 1

DOACs

11 sessions
What are the challeges of DOACs and are alternatives needed?	Watch now
What factors influence your choice of DOAC?	Watch now
Do you have a DOAC you prescribe more frequently?	Watch now
What are the most important anticoagulation clinical trials?	Watch now
Do you have a DOAC of choice?	Watch now
How important are reversal agents? - Christoper Cannon	Watch now
How important are reversal agents? - Moussa Mansour	Watch now
Are you once-daily or twice-daily? - Christopher Cannon	Watch now
Are you once-daily or twice-daily? - Moussa Mansour	Watch now
Is RCT or real-world data more important to you? - Christopher Cannon	Watch now
Is RCT or real-world data more important to you? - Moussa Mansour	Watch now

Faculty Biographies

Moussa Mansour

Moussa Mansour

Associate Professor of Medicine

Dr Moussa Mansour is the Director of the Cardiac Electrophysiology Laboratory and Director of the Atrial Fibrillation Program at Massachusetts General Hospital. Dr Mansour has published extensively in the field of cardiac arrhythmia, specifically the area of atrial fibrillation. He is involved in cutting edge research and currently participating in the development of new catheters for the treatment of atrial fibrillation.

View full profile